Ketamine-New Possibilities in the Treatment of Depression: A Narrative Review.

Kowalczyk, Mateusz; Kowalczyk, Edward; Kwiatkowski, Pawel; Lopusiewicz, Lukasz; Sienkiewicz, Monika; Talarowska, Monika

Kowalczyk, Mateusz; Kowalczyk, Edward; Kwiatkowski, Pawel; Lopusiewicz, Lukasz; Sienkiewicz, Monika; Talarowska, Monika.

Afiliación

Kowalczyk M; Babinski Memorial Hospital, Aleksandrowska St. 159, 91-229 Lodz, Poland.
Kowalczyk E; Department of Pharmacology and Toxicology, Medical University of Lodz, Zeligowskiego St. 7/9, 90-752 Lodz, Poland.
Kwiatkowski P; Department of Diagnostic Immunology, Pomeranian Medical University in Szczecin, Powstanców Wielkopolskich 72, 70-111 Szczecin, Poland.
Lopusiewicz L; Center of Bioimmobilisation and Innovative Packaging Materials, Faculty of Food Sciences and Fisheries, West Pomeranian University of Technology Szczecin, Janickiego 35, 71-270 Szczecin, Poland.
Sienkiewicz M; Department of Pharmaceutical Microbiology and Microbiological Diagnostic, Medical University of Lodz, Muszynskiego St. 1, 90-151 Lodz, Poland.
Talarowska M; Department of Clinical Psychology and Psychopathology, Institute of Psychology, University of Lodz, Smugowa St. 10/12, 91-433 Lodz, Poland.

Life (Basel) ; 11(11)2021 Nov 05.

Article en En | MEDLINE | ID: mdl-34833062

Palabras clave

COVID-19 pandemic; GABA; NMDA receptor; anxiety; depression; ketamine; neurodegeneration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Life (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google